Isabella Huettner
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern.
Journal: PLoS pathogens
Published: July 06, 2022
Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans.
Journal: Cell reports
Published: October 21, 2021
SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies.
Journal: eLife
Published: October 06, 2021
ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition-implications for COVID-19.
Journal: International journal of obesity (2005)
Published: June 24, 2021
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort.
Journal: AIDS (London, England)
Published: June 15, 2021
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections.
Journal: medRxiv : the preprint server for health sciences
Published: June 15, 2021
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike.
Journal: bioRxiv : the preprint server for biology
Published: February 10, 2021
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant.
Journal: Immunity
Published: February 03, 2021
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.
Journal: Nature microbiology
Published: July 08, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026